Smallcap investors largely see the psychedelics space in one of two ways; you’re either in the ‘this may be big one day but there’s not a lot of fat…
Research
On November 11, 2020 Revive Therapeutics (RVV.C) Revive Therapeutics updated shareholders on its oral thin-film delivery system with psilocybin being developed “under a research partnership agreement with Reed Research…
Medipharm Labs Inc, a subsidiary of Medipharm Labs (LABS.T), kicked off a clinical trial to determine the effectiveness of Medipharm Labs’ medical cannabis products and formulations on treating end-stage…
Increased product efficacy and patient convenience is anticipated through faster onset of drug action, more predictable therapeutic activity and ease of use….
Formerly dismissed-by-many pharmaceutical company Revive Therapeutics (RVV.C) jumped a whopping 68% Friday upon revealing it has been granted approval to move forward with phase 3 clinical trials on the…
Radient Technologies’ (RTI.V) bioU products will now be available for patients to use during the recently announced University Health Networks’ (UHN) medical cannabis real world evidence study (MC-RWE), according…
Nextleaf Solutions (OILS.C) received their 40th patent today from the Canadian Intellectual Property Office, according to a press release. The patent is regarding a process for acetylating THC and…
WeedMD (WMD.V) launched their Aurum vapes to Starseed patients across Canada as part of the company’s expanding medical cannabis portfolio offerings today. Cannabis 2.0 has been live for almost…
Charlotte’s Web Holdings (CWEB.T) is banding together with six other CBD brands to support ValidCare’s scientific study to answer questions posed by the Food and Drug Administration (FDA) about…
Vektor is now proceeding with process implementation for the manufacture of Rotigotine patches for human clinical studies….